Octamer_NN
transcription_NN
factors_NNS
and_CC
the_DT
cell_NN
type-specificity_NN
of_IN
immunoglobulin_NN
gene_NN
expression_NN
._.

Antibodies_NNS
are_VBP
produced_VBN
exclusively_RB
in_IN
B_NN
lymphocytes_NNS
._.

The_DT
expression_NN
of_IN
the_DT
antibody-encoding_JJ
genes_NNS
,_,
the_DT
immunoglobulin_NN
-LRB-_-LRB-
Ig_NN
-RRB-_-RRB-
genes_NNS
,_,
is_VBZ
also_RB
restricted_JJ
to_TO
B_NN
cells_NNS
._.

The_DT
octamer_NN
sequence_NN
ATGCAAAT_NN
is_VBZ
present_JJ
in_IN
the_DT
promoter_NN
and_CC
the_DT
enhancer_NN
of_IN
Ig_NN
genes_NNS
,_,
and_CC
plays_VBZ
an_DT
important_JJ
role_NN
in_IN
its_PRP$
tissue-specific_JJ
expression_NN
._.

This_DT
sequence_NN
motif_NN
is_VBZ
a_DT
binding_VBG
site_NN
for_IN
nuclear_JJ
proteins_NNS
,_,
the_DT
so-called_JJ
octamer_NN
transcription_NN
factors_NNS
-LRB-_-LRB-
Oct_NN
or_CC
OTF_NN
factors_NNS
-RRB-_-RRB-
._.

The_DT
Oct-1_NN
protein_NN
is_VBZ
present_JJ
in_IN
all_DT
cell_NN
types_NNS
analyzed_VBN
so_RB
far_RB
,_,
whereas_IN
Oct-2A_NN
and_CC
Oct-2B_NN
are_VBP
found_VBN
mainly_RB
in_IN
B_NN
lymphocytes_NNS
._.

All_DT
three_CD
proteins_NNS
show_VBP
the_DT
same_JJ
sequence_NN
specificity_NN
and_CC
binding_NN
affinity_NN
._.

It_PRP
appears_VBZ
that_IN
the_DT
B_NN
cell-specific_JJ
expression_NN
of_IN
Ig_NN
genes_NNS
is_VBZ
mediated_VBN
at_IN
least_JJS
in_IN
part_NN
by_IN
cell_NN
type-specific_JJ
Oct_NN
factors_NNS
,_,
and_CC
that_IN
there_EX
are_VBP
both_CC
quantitative_JJ
and_CC
qualitative_JJ
differences_NNS
between_IN
Oct-1_NN
and_CC
Oct-2_NN
factors_NNS
._.

Recently_RB
,_,
a_DT
number_NN
of_IN
other_JJ
octamer_NN
factor_NN
variants_NNS
were_VBD
identified_VBN
._.

Many_JJ
of_IN
these_DT
may_MD
be_VB
created_VBN
by_IN
alternative_JJ
splicing_NN
of_IN
a_DT
primary_JJ
transcript_NN
of_IN
one_CD
Oct_NN
factor_NN
gene_NN
and_CC
may_MD
serve_VB
a_DT
specific_JJ
function_NN
in_IN
the_DT
fine_JJ
tuning_NN
of_IN
gene_NN
expression_NN
._.

